Christophe Douat
Chief Executive Officer at MEDINCELL S.A.
Net worth: 10 M $ as of 2024-04-29
Christophe Douat active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MEDINCELL S.A. | Chief Executive Officer | 2003-01-08 | - |
| Founder | 2003-01-08 | - | |
| Great North SARL | Chairman | - | - |
CM Biomaterials BV
 CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing CM Biomaterials BV is a Dutch company that manufactures plastic products. The joint venture company is based in Gorinchem, Netherlands. | Director/Board Member | - | - |
Career history of Christophe Douat
Former positions of Christophe Douat
| Companies | Position | Start | End |
|---|---|---|---|
| NANOBIOTIX | Director/Board Member | 2011-06-27 | 2016-12-31 |
| Independent Dir/Board Member | 2011-06-27 | 2016-12-31 | |
Matignon Investissement et Gestion SAS
 Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Private Equity Investor | 2000-12-31 | 2010-04-30 |
| Matignon Technologies | Corporate Officer/Principal | 2001-03-31 | 2009-03-31 |
| NANOBIOTIX | Director/Board Member | 2005-12-31 | 2008-12-31 |
| Sabourin Lake Lodge | Corporate Officer/Principal | 1991-12-31 | 1996-12-31 |
Matignon Technologies II FCPR
 Matignon Technologies II FCPR Investment ManagersFinance Matignon Technologies II FCPR invests in early to later-stage companies mostly located in France and the European Union. It focuses on companies in the medical field or in the information technology sectors with revenues below €50 million. It invests between €500,000 and €10 million from early stage to growth operations. | Founder | - | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Christophe Douat
| École Nationale Supérieure des Mines de Paris | Undergraduate Degree |
| University of Minnesota | Graduate Degree |
| University of Calgary | Masters Business Admin |
Statistics
International
| France | 10 |
| Canada | 3 |
| United States | 2 |
Operational
| Director/Board Member | 5 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| NANOBIOTIX | Health Technology |
| MEDINCELL S.A. | Health Technology |
| Private companies | 8 |
|---|---|
Matignon Investissement et Gestion SAS
Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Finance |
Arterial Remodelling Technologies SA
 Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Health Technology |
| Great North SARL | |
Groupement International d'Informatique de Santé SA
 Groupement International d'Informatique de Santé SA Publishing: Books/MagazinesConsumer Services Groupement International d'Informatique de Santé SA engages in the management of an online health and nutrition portal. Its services include daily effectiveness index, weekly synthesis, dietitian consultation, LeDiet community, practical tools, and chef and LeDiet recipes. The company was founded on October 9, 1986 and is headquartered in Paris, France. | Consumer Services |
CM Biomaterials BV
CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing CM Biomaterials BV is a Dutch company that manufactures plastic products. The joint venture company is based in Gorinchem, Netherlands. | Producer Manufacturing |
| Sabourin Lake Lodge | |
| Matignon Technologies | |
Matignon Technologies II FCPR
Matignon Technologies II FCPR Investment ManagersFinance Matignon Technologies II FCPR invests in early to later-stage companies mostly located in France and the European Union. It focuses on companies in the medical field or in the information technology sectors with revenues below €50 million. It invests between €500,000 and €10 million from early stage to growth operations. | Finance |
- Stock Market
- Insiders
- Christophe Douat
- Experience
